Share-based Compensation (Tables)

9 Months Ended

Dec. 31, 2025

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Summary of share-based compensation expense

The following table summarizes the share-based compensation expense for grants included in the condensed consolidated statements of operations:

	Three Months Ended December 31,				Nine Months Ended December 31,
(In thousands)	2025		2024		2025		2024
Product development	$	3,422	$	2,293	$	9,429	$	7,199
Sales and marketing		555		541		1,531		1,115
General and administrative		1,792		1,384		4,838		4,342
Total share-based compensation expense	$	5,769	$	4,218	$	15,798	$	12,656

Activity related SSARs award

The following table summarizes the activity during the nine months ended December 31, 2025 for SSARs awarded under the 2020 and 2016 Plans:

(In thousands, except share and per share data)	Number of Rights			Weighted-Average Exercise Price		Remaining Contractual Term		Aggregate Intrinsic Value
				(per right)		(in years)
Outstanding at April 1, 2025		394,959		$	20.04
Granted		—			—
Exercised		(45,421	)		19.90
Forfeited		—			—
Expired		—			—
Outstanding at December 31, 2025		349,538		$	20.06		1.4	$	34,528
Exercisable at December 31, 2025		349,538		$	20.06		1.4	$	34,528
Vested at December 31, 2025		349,538		$	20.06		1.4	$	34,528

Activity related to restricted shares granted by the Company

The following table summarizes the activity during the nine months ended December 31, 2025 for restricted shares granted under the 2020 Plan:

	Number of Shares			Weighted-Average Grant-Date Fair Value
				(per share)
Outstanding at April 1, 2025		229,710		$	76.01
Granted		4,970			100.19
Vested		(154,821	)		67.31
Forfeited		(3,524	)		93.50
Expected to vest at December 31, 2025		76,335		$	94.49

Employee Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of principal assumptions utilized in valuing service condition SARs

We estimate the value of the call and put options using the Black-Scholes-Merton option pricing model with inputs including the closing market price of our common stock on the first date of the offering period and assumptions regarding the risk-free interest rate, expected term, and expected volatility of our common shares over the offering period based on historical volatility.

	Offering Period Ended			Offering Period Ended			Offering Period Ended			Offering Period Ended
	December 31, 2025			June 30, 2025			December 31, 2024			June 30, 2024
Grant date fair value	$	115.19		$	131.71		$	103.43		$	81.60
Risk-free interest rate over contractual term		4.30	%		4.31	%		4.91	%		5.36	%
Expected term (in years)		0.50			0.49			0.50			0.41
Expected volatility		60.10	%		42.40	%		40.93	%		47.41	%

Restricted Stock Units (RSUs) [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Activity related to restricted shares granted by the Company

The following table summarizes the activity during nine months ended December 31, 2025 for restricted stock units awarded under the 2020 and 2024 Plans:

	Number of Shares			Weighted-Average Grant-Date Fair Value
				(per share)
Outstanding at April 1, 2025		181,195		$	118.90
Granted		208,051			126.28
Vested		(43,010	)		137.34
Forfeited		(5,783	)		134.03
Expected to vest at December 31, 2025		340,453		$	120.83